636 related articles for article (PubMed ID: 30834661)
41. Prediction of placenta accreta by ultrasonography and color Doppler imaging.
Woodring TC; Klauser CK; Bofill JA; Martin RW; Morrison JC
J Matern Fetal Neonatal Med; 2011 Jan; 24(1):118-21. PubMed ID: 20446895
[TBL] [Abstract][Full Text] [Related]
42. First-trimester prediction of surgical outcome in abnormally invasive placenta using the cross-over sign.
Calì G; Forlani F; Minneci G; Foti F; Di Liberto S; Familiari A; Scambia G; D'Antonio F
Ultrasound Obstet Gynecol; 2018 Feb; 51(2):184-188. PubMed ID: 28233462
[TBL] [Abstract][Full Text] [Related]
43. Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum.
Zhang J; Li H; Feng D; Wu J; Wang Z; Feng F
BMC Pregnancy Childbirth; 2023 Aug; 23(1):569. PubMed ID: 37550654
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive surgical staging for placenta accreta spectrum.
Palacios-Jaraquemada JM; Basanta N; Nieto-Calvache Á; Aryananda RA
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10660-10666. PubMed ID: 36543387
[TBL] [Abstract][Full Text] [Related]
45. Separation sign: novel ultrasound sign for ruling out diagnosis of placenta accreta spectrum.
Allwood RX; Self A; Collins SL
Ultrasound Obstet Gynecol; 2022 Sep; 60(3):390-395. PubMed ID: 35837717
[TBL] [Abstract][Full Text] [Related]
46. Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface.
Jauniaux E; Hussein AM; Elbarmelgy RM; Elbarmelgy RA; Burton GJ
Am J Obstet Gynecol; 2022 Feb; 226(2):243.e1-243.e10. PubMed ID: 34461077
[TBL] [Abstract][Full Text] [Related]
47. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness.
Jauniaux E; Collins SL; Jurkovic D; Burton GJ
Am J Obstet Gynecol; 2016 Dec; 215(6):712-721. PubMed ID: 27473003
[TBL] [Abstract][Full Text] [Related]
48. Predicting Placenta Accreta Spectrum: Validation of the Placenta Accreta Index.
Happe SK; Yule CS; Spong CY; Wells CE; Dashe JS; Moschos E; Rac MWF; McIntire DD; Twickler DM
J Ultrasound Med; 2021 Aug; 40(8):1523-1532. PubMed ID: 33058255
[TBL] [Abstract][Full Text] [Related]
49. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa.
Melcer Y; Jauniaux E; Maymon S; Tsviban A; Pekar-Zlotin M; Betser M; Maymon R
Am J Obstet Gynecol; 2018 Apr; 218(4):443.e1-443.e8. PubMed ID: 29353034
[TBL] [Abstract][Full Text] [Related]
50. Three-dimensional volume rendering ultrasound for assessing placenta accreta spectrum severity and discriminating it from simple scar dehiscence.
Adu-Bredu TK; Ridwan R; Aditiawarman A; Ariani G; Collins SL; Aryananda RA
Am J Obstet Gynecol MFM; 2024 Apr; 6(4):101321. PubMed ID: 38460827
[TBL] [Abstract][Full Text] [Related]
51. The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth.
Jauniaux E; Hussein AM; Thabet MM; Elbarmelgy RM; Elbarmelgy RA; Jurkovic D
Am J Obstet Gynecol; 2023 Oct; 229(4):445.e1-445.e11. PubMed ID: 37187303
[TBL] [Abstract][Full Text] [Related]
52. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.
Jauniaux E; Collins S; Burton GJ
Am J Obstet Gynecol; 2018 Jan; 218(1):75-87. PubMed ID: 28599899
[TBL] [Abstract][Full Text] [Related]
53. Two-dimensional ultrasound signs as predictive markers of massive peri-operative blood loss in placenta previa suspicious for placenta accreta spectrum (PAS) disorder.
Watthanasathitnukun W; Pranpanus S; Petpichetchian C
PLoS One; 2022; 17(10):e0276153. PubMed ID: 36240191
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of MRI-based scoring models for predicting placental invasiveness in high-risk women for placenta accreta spectrum.
Liu Q; Zhou W; Yan Z; Li D; Lou T; Yuan Y; Rong P; Feng Z
Eur Radiol; 2024 Feb; 34(2):957-969. PubMed ID: 37589907
[TBL] [Abstract][Full Text] [Related]
55. Sensitivity of antenatal ultrasound in diagnosing posterior placenta accreta spectrum disorders.
Dellapiana G; Mok T; Platt LD; Silverman NS; Han CS; Esakoff TF
J Perinat Med; 2024 Mar; 52(3):288-293. PubMed ID: 38243911
[TBL] [Abstract][Full Text] [Related]
56. The impact of preoperative ultrasound and intraoperative findings on surgical outcomes in patients at high risk of placenta accreta spectrum.
Hussein AM; Fox K; Bhide A; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
BJOG; 2023 Jan; 130(1):42-50. PubMed ID: 36054504
[TBL] [Abstract][Full Text] [Related]
57. Development of a training program for the ultrasound screening of placenta accreta spectrum disorders.
Dimitrova I; Jauniaux E; Zosmer N; De Stefani LB; Andrade W; Bourmpaki E; Bunce C; Nicholaides KH
Int J Gynaecol Obstet; 2019 Oct; 147(1):73-77. PubMed ID: 31265126
[TBL] [Abstract][Full Text] [Related]
58. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.
Lucidi A; Jauniaux E; Hussein AM; Coutinho CM; Tinari S; Khalil A; Shamshirsaz A; Palacios-Jaraquemada JM; D'Antonio F
Ultrasound Obstet Gynecol; 2023 Nov; 62(5):633-643. PubMed ID: 37401769
[TBL] [Abstract][Full Text] [Related]
59. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa.
Mulla BM; Weatherford R; Redhunt AM; Modest AM; Hacker MR; Hecht JL; Spiel MH; Shainker SA
Arch Gynecol Obstet; 2019 Dec; 300(6):1601-1606. PubMed ID: 31691015
[TBL] [Abstract][Full Text] [Related]
60. Prophylactic radiologic interventions to reduce postpartum hemorrhage in women with risk factors for placenta accreta spectrum disorder: a nationwide cohort study.
Bonsen LR; Harskamp V; Feddouli S; Bloemenkamp KWM; Duvekot JJ; Pors A; van Roosmalen J; Zwart JJ; van Lith JMM; Hendriks J; Urlings TAJ; van den Akker T; van der Bom JG; Henriquez DDCA;
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2251076. PubMed ID: 37673791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
